Fabien Zoulim

Université Claude Bernard Lyon 1

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (12)

Marcus Vinicius Guimarães de Lacerda

Adjunct Professor

University of Texas Medical Branch

UNITED STATES

View details

Barbara Testoni

FRANCE

View details

Milan J. Sonneveld

NETHERLANDS

View details

Anna SF Lok

University of Michigan

UNITED STATES

View details

Boyan Grigorov

Associate Professor

Université Claude Bernard Lyon 1

FRANCE

View details

Florian van Bömmel

Professor of Medicine

University Hospital Leipzig

GERMANY

View details

Thierry Verbinnen

Janssen Pharmaceutica NV

BELGIUM

View details

Nicole Erler

Erasmus University Rotterdam

NETHERLANDS

View details

Romain Parent

FRANCE

View details

Marc-David Ruepp

King’s College London

UNITED KINGDOM

View details

Huldrych Günthard

Professor, MD

University Hospital of Zurich

SWITZERLAND

View details

Javier Crespo

Profesor Titular

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Fabien Zoulim

Research Interests

Explore related searches

Contact this professor

Articles (30)

Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis

Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled clinical trial.

IFN-β production promotes metabolic rewiring and protection against oxidative stress in hepatitis delta virus-infected hepatocyte cultures.

Mortality risk in migrant and non-migrant individuals with chronic hepatitis B virus infection: a French hospital-based cohort study (ANRS CO22 HEPATHER).

Getting to HBV cure—Will new biomarkers help?

Behaviour-Based Predictive Scores of Hepatocellular Carcinoma in People With Chronic Hepatitis B (ANRS CO22 HEPATHER).

Liver Enzyme Elevation After Hepatitis C Virus Cure: Is There a Sex Effect? (ANRS CO13 HEPAVIH Cohort)

New potent HBV replication inhibitors for the management of chronic hepatitis B are needed

Individual mHLA-DR trajectories in the ICU as predictors of early infections following liver transplantation: a prospective observational study.

Low CD4 cell count is associated with post-hepatitis C virus cure mortality in people living with HIV (ANRS CO13 HEPAVIH cohort).

After the Storm: Persistent Molecular Alterations Following HCV Cure

Circulating HBV RNA and hepatitis B core-related antigen trajectories in persons with HIV/HBV coinfection and HBsAg loss on tenofovir therapy.

Co-Transcriptional Regulation of HBV Replication: RNA Quality Also Matters

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial

Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study

Axon guidance molecules in liver pathology: Journeys on a damaged passport.

The Hepatitis B Virus Genotypes E to J: The Overlooked Genotypes

Comparison of Pathway Referrals for Liver Fibrosis Risk Stratification Performed in Diabetology and Nutrition Clinics.

Substance use and CD4/CD8 ratio in HIV/HCV co-infected people receiving direct-acting antiviral treatment (ANRS CO13 HEPAVIH).

Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study.

Emerging anti-HDV drugs and HBV cure strategies with anti-HDV activity.

New perspectives on development of curative strategies for chronic hepatitis B.

Assessment of neutrophil subsets and immune checkpoint inhibitor expressions on T lymphocytes in liver transplantation: A preliminary study beyond the neutrophil-lymphocyte ratio.

G-quadruplexes control hepatitis B virus replication by promoting cccDNA transcription and phase separation in hepatocytes

A fluorescent Ponceau S-based total protein normalization method for conventional and challenging immunoblot samples

Cytosine base editing inhibits hepatitis B virus replication and reduces HBsAg expression <i>in vitro</i> and <i>in vivo</i>.

Hepatitis C virus cure from direct-acting antivirals and mortality: Are people with and without a history of injection drug use in the same boat? (ANRS CO22 Hepather cohort).

Spatial transcriptomics reveals a low extent of transcriptionally active hepatitis B virus integration in patients with HBsAg loss.

Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy.

Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B.

Collaborators (12)

Marcus Vinicius Guimarães de Lacerda

Barbara Testoni

Milan J. Sonneveld

Anna SF Lok

Boyan Grigorov

Florian van Bömmel

Thierry Verbinnen

Nicole Erler

Romain Parent

Marc-David Ruepp

Huldrych Günthard

Javier Crespo

Make your next move.